Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity Journal Article


Authors: Korshunov, A.; Sturm, D.; Ryzhova, M.; Hovestadt, V.; Gessi, M.; Jones, D. T. W.; Remke, M.; Northcott, P.; Perry, A.; Picard, D.; Rosenblum, M.; Antonelli, M.; Aronica, E.; Schüller, U.; Hasselblatt, M.; Woehrer, A.; Zheludkova, O.; Kumirova, E.; Puget, S.; Taylor, M. D.; Giangaspero, F.; Peter Collins, V.; Von Deimling, A.; Lichter, P.; Huang, A.; Pietsch, T.; Pfister, S. M.; Kool, M.
Article Title: Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity
Abstract: Three histological variants are known within the family of embryonal rosette-forming neuroepithelial brain tumors. These include embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma (EBL), and medulloepithelioma (MEPL). In this study, we performed a comprehensive clinical, pathological, and molecular analysis of 97 cases of these rare brain neoplasms, including genome-wide DNA methylation and copy number profiling of 41 tumors. We identified uniform molecular signatures in all tumors irrespective of histological patterns, indicating that ETANTR, EBL, and MEPL comprise a single biological entity. As such, future WHO classification schemes should consider lumping these variants into a single diagnostic category, such as embryonal tumor with multilayered rosettes (ETMR). We recommend combined LIN28A immunohistochemistry and FISH analysis of the 19q13.42 locus for molecular diagnosis of this tumor category. Recognition of this distinct pediatric brain tumor entity based on the fact that the three histological variants are molecularly and clinically uniform will help to distinguish ETMR from other embryonal CNS tumors and to better understand the biology of these highly aggressive and therapy-resistant pediatric CNS malignancies, possibly leading to alternate treatment strategies. © 2013 The Author(s).
Keywords: immunohistochemistry; child; controlled study; human tissue; preschool child; cancer surgery; major clinical study; clinical feature; histopathology; cancer combination chemotherapy; multimodality cancer therapy; cancer radiotherapy; brain tumor; antineoplastic agent; genetic analysis; tumor differentiation; gene locus; genetic association; dna methylation; childhood cancer; fluorescence in situ hybridization; dna; infant; molecular recognition; newborn; neuroepithelioma; world health organization; tumor classification; molecular diagnosis; ependymoblastoma; embryonal tumor with abundant neuropil and true rosettes; human; male; female; priority journal; article; embryonal tumor with multilayered rosettes
Journal Title: Acta Neuropathologica
Volume: 128
Issue: 2
ISSN: 0001-6322
Publisher: Springer  
Date Published: 2014-08-01
Start Page: 279
End Page: 289
Language: English
DOI: 10.1007/s00401-013-1228-0
PROVIDER: scopus
PMCID: PMC4102829
PUBMED: 24337497
DOI/URL:
Notes: Export Date: 1 October 2014 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Marc Rosenblum
    411 Rosenblum